Skip to content

Efficacy of highly purified HMG vs. HMG on pregnancy outcomes in vitro fertilization

Efficacy of highly purified HMG vs. HMG with rFSH on pregnancy outcomes in vitro fertilization

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-OPR-15006204
Enrollment
Unknown
Registered
2015-03-28
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

rFSH+HP-HMG:HP-HMG
HP-HMG:HP-HMG

Sponsors

Northwest Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. maternal age 5.

Exclusion criteria

Exclusion criteria: 1. hydrosalpinx; 2. endometriosis; 3. uterine malformation.

Design outcomes

Primary

MeasureTime frame
pregnancy rate;

Countries

China

Contacts

Public ContactLiu Shan
123564787@qq.com+86 18991932450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026